560 related articles for article (PubMed ID: 21162645)
21. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease.
Pampura AN; Papadopoulos NG; Spičák V; Kurzawa R
Int Arch Allergy Immunol; 2011; 155(4):367-78. PubMed ID: 21346367
[TBL] [Abstract][Full Text] [Related]
22. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.
Nathan RA
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):182-90; quiz 190-1, 232. PubMed ID: 12602664
[TBL] [Abstract][Full Text] [Related]
23. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
[No Abstract] [Full Text] [Related]
24. Loratadine, a non-sedating H1-receptor antagonist (antihistamine).
Simons FE
Ann Allergy; 1989 Oct; 63(4):266-8. PubMed ID: 2572187
[No Abstract] [Full Text] [Related]
25. [Drug therapy in allergic rhinitis].
Heppt W
HNO; 1997 Aug; 45(8):647-55. PubMed ID: 9378674
[No Abstract] [Full Text] [Related]
26. Cetirizine: a unique second-generation antihistamine for treatment of rhinitis and chronic urticaria.
Pierson WE
Clin Ther; 1991; 13(1):92-9. PubMed ID: 1674232
[TBL] [Abstract][Full Text] [Related]
27. Antihistamines in allergic rhinitis.
Culver S; Parks BR
Pediatr Nurs; 1989; 15(6):615-6. PubMed ID: 2575736
[No Abstract] [Full Text] [Related]
28. [The place of new antihistamines in allergy management. Apropos of desloratadine].
Sabbah A
Allerg Immunol (Paris); 2002 Dec; 34(10):377-83. PubMed ID: 12575624
[TBL] [Abstract][Full Text] [Related]
29. Antihistamine therapy in allergic rhinitis.
Tarnasky PR; Van Arsdel PP
J Fam Pract; 1990 Jan; 30(1):71-80. PubMed ID: 1967182
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis.
Katiyar S; Prakash S
Prim Care Respir J; 2009 Jun; 18(2):57-68. PubMed ID: 18695846
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of H1-antihistamines.
Blaiss MS
Clin Allergy Immunol; 2002; 17():319-36. PubMed ID: 12113222
[TBL] [Abstract][Full Text] [Related]
32. [Total review of all results collected worldwide with astemizole (Hismanal)].
Rombaut N; Vanden Bussche G
Z Hautkr; 1985; 60 Suppl 1():29-42. PubMed ID: 2859711
[TBL] [Abstract][Full Text] [Related]
33. Three new non-sedative antihistamines: worth keeping an eye open for.
Drug Ther Bull; 1990 May; 28(10):38-40. PubMed ID: 1983393
[No Abstract] [Full Text] [Related]
34. Antihistamines in rhinoconjunctivitis.
Howarth P
Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
[TBL] [Abstract][Full Text] [Related]
35. The clinical evidence of second-generation H1-antihistamines in the treatment of allergic rhinitis and urticaria in children over 2 years with a special focus on rupatadine.
Nieto A; Nieto M; Mazón Á
Expert Opin Pharmacother; 2021 Mar; 22(4):511-519. PubMed ID: 33198523
[TBL] [Abstract][Full Text] [Related]
36. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
37. Clinical profile of astemizole. A survey of 50 double-blind trials.
Vanden Bussche G; Emanuel MB; Rombaut N
Ann Allergy; 1987 Mar; 58(3):184-8. PubMed ID: 2881507
[TBL] [Abstract][Full Text] [Related]
38. Focusing into new challenges in allergic rhinitis and urticaria. Introduction.
Valero Santiago AL
J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():1. PubMed ID: 22185043
[No Abstract] [Full Text] [Related]
39. Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
Clissold SP; Sorkin EM; Goa KL
Drugs; 1989 Jan; 37(1):42-57. PubMed ID: 2523301
[TBL] [Abstract][Full Text] [Related]
40. Antiallergic anti-inflammatory effects of H1-antihistamines in humans.
Assanasen P; Naclerio RM
Clin Allergy Immunol; 2002; 17():101-39. PubMed ID: 12113215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
